IC
NMRA icon

Iconiq Capital’s Neumora Therapeutics NMRA Stock Holding History

Iconiq Capital’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.35M Hold
2,559,090
– – 0.13% 37
2026
Q1 		$4.99M Hold
2,559,090
– – 0.11% 37
2025
Q4 		$4.58M Hold
2,559,090
– – 0.07% 42
2025
Q3 		$4.66M Hold
2,559,090
– – 0.06% 46
2025
Q2 		$1.88M Hold
2,559,090
– – 0.03% 63
2025
Q1 		$2.56M Hold
2,559,090
– – 0.05% 53
2024
Q4 		$27.1M Sell
2,559,090
-839,538
-25% -$10.1M 0.42% 21
2024
Q3 		$44.9M Hold
3,398,628
– – 0.96% 12
2024
Q2 		$33.4M Hold
3,398,628
– – 0.72% 14
2024
Q1 		$46.7M Hold
3,398,628
– – 0.81% 11
2023
Q4 		$57.9M Buy
+3,398,628
New +$41.7M 1.08% 11

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Iconiq Capital's NMRA Position: Q2 2026 in Review

Iconiq Capital held its Neumora Therapeutics (NMRA) position steady in Q2 2026 at 2,559,090 shares worth $4.35M. The position accounts for 0.13% of the portfolio, ranked #37.

Iconiq Capital first reported a position in NMRA in Q4 2023 and has held it in 11 quarters since. The position peaked at $57.9M in Q4 2023. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • Iconiq Capital held 2,559,090 shares of Neumora Therapeutics worth $4.35M as of Q2 2026.
  • Iconiq Capital left its Neumora Therapeutics share count unchanged in Q2 2026.
  • Neumora Therapeutics made up 0.13% of Iconiq Capital's portfolio in Q2 2026, its #37 holding.
  • Iconiq Capital first reported a position in Neumora Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • Iconiq Capital's Neumora Therapeutics position peaked at $57.9M in Q4 2023.
  • 113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on Iconiq Capital's 13F filing for Q2 2026, filed 13 Aug 2026.